Cargando…
Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising...
Autores principales: | Libuit, Jessica, Whitman, Andrew, Wolfe, Rebecca, Washington, Casey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324182/ https://www.ncbi.nlm.nih.gov/pubmed/25734080 http://dx.doi.org/10.1093/ofid/ofu006 |
Ejemplares similares
-
Candidemia in Febrile Neutropenic Patients; a Brief Report
por: Yousefi, Maysam, et al.
Publicado: (2018) -
A Comparative Study of Piperacillin-Tazobactam With and Without Vancomycin as Empirical Therapy for Febrile Neutropenic Patients With Solid Tumor Malignancies
por: Sirkhazi, Mansoor, et al.
Publicado: (2015) -
Vancomycin Dosing in Neutropenic Patients
por: Haeseker, Michiel B., et al.
Publicado: (2014) -
Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis
por: Vossen, Matthias Gerhard, et al.
Publicado: (2018) -
Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023)